› Forums › Herpes Questions › Questions about Shedding
- This topic has 3 replies, 2 voices, and was last updated 10 years, 1 month ago by Terri Warren.
-
AuthorPosts
-
-
September 30, 2016 at 1:59 pm #15470NotMeParticipant
Dear Terri
I am a female who has had herpes for 20 years. To my knowledge I’ve never had a genital OB only on buttocks.
I used to get many OBs before starting daily Valtrex (1 gram)12 years ago. Since then I’ve had maybe 5 total all near my tailbone and all pretty minor.
I’m curious about shedding. I believe I read somewhere on this forum that if you have an OB on the buttocks, there’s a 25% chance you are also shedding from the genital tract at the same time. Is that correct? If so then it’s more likely than not, during an OB, to just be shedding from the lesion on the buttocks only?
And does Valtrex reduce the amount of virus you shed during an OB and/or shorten the amount of time you shed? Or does it just reduce shedding during the asymptomatic times?
Lastly is there any research which shows for those who have never had an actual genital OB, do we shed less often asymptomatically than people who have genital OBs?
-
October 4, 2016 at 6:55 am #15489Terri WarrenKeymaster
Your statistics are correct. The problem is you cannot know which times you are shedding genitally and when you are not. Valtrex reduces the amount of virus shed and shortens the duration of outbreaks and likely the duration of shedding as well, during outbreaks and inbetween.
There is no research about the question that you ask because you aren’t really asymptomatic – you just are symptomatic at a different location. For people who have never had any symptoms in the boxer shorts area, they do shed less overall than people who have had outbreaks anywhere in the genital area.
Also, it is likely that have had a genital outbreak at some point and either it was so minor you missed it OR you confused it with another diagnosis – yeast infection, UTI, etc. First outbreaks don’t show up on the buttocks – those are recurrences, generally speaking.
Terri
-
October 4, 2016 at 10:21 am #15492NotMeParticipant
Thank you Terri. I just know I had a massive sacral outbreak one week post exposure 20 years ago with no genital symptoms. I guess its possible I had an OB on my cervix or something at the same time. I’ve never seen or felt anything “down there” since. I have had maybe 2-3 yeast infections over the years but they corresponded to recent antibiotic therapy and healed promptly after the 1 day OTC Monistat treatment.
Just a few somewhat unrelated follow up questions:
1. Have you in your years of practice had patients in discordant relationships not transmit the virus using suppressive therapy and/or condom usage? Is one of those better than the other to help reduce transmission? (I realize both together offer best protection). I’ve seen the results of the Valtrex study by as that was only one study just not sure if that reflects ‘real life’. They also only used 500mg in that study so wondering if 1 gram would have yielded better results.
2. Why does Valtrex reduce shedding by 70-80% but transmission by only 50? It seems to me if you’re not shedding you can’t transmit? That statistic never made sense to me.
3. I’ve been seeing a lot in the news about Gen 003. But preliminary results don’t look as good as shedding reduction with Valtrex. So what is the excitement all about? Maybe I am missing something. Pritelivir looks to have had better results so far assuming it can make it through the next stages of testing.
-
October 7, 2016 at 12:12 pm #15529Terri WarrenKeymaster
I have absolutely had many many patients in discordant relationships who did not transmit. Absolutely! In fact, most people who use condoms and suppression never transmit. One gram actually offers little improvement over 500 mg (Chritine’s Johnson article on this).
I also was initially confused by the difference between 50% and 70%. There are other issues involved in transmission – the immune status of the uninfected partner, possible breaks in the skin that are not recognized, things like that.
The Gen data is actually very good and close to Valtrex. Not quite as good but close. The next question I think should be explored is the combination of Valtrex and Gen and that study will be done, I believe, soon. Pritelivir was so exciting but put on hold due to some animal toxicity studies – don’t know if it will ever restart at this point.
Terri
-
-
AuthorPosts
You must register to ask your own question or be logged in to reply to this question.